ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

CABA Cabaletta Bio Inc

12.09
1.45 (13.57%)
시간외 거래
최종 업데이트: 07:43:11
15분 지연
기업명 주식 심볼 시장 주식 타입
Cabaletta Bio Inc CABA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
1.45 13.57% 12.09 07:43:11
개장가 저가 고가 종가 전일 종가
10.60 10.555 12.69 12.41 10.645
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
21/03/202420:00GLOBECabaletta Bio Reports Fourth Quarter and Full Year 2023..
20/03/202420:00GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
05/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202422:00GLOBECabaletta Bio to Participate in Upcoming Investor..
14/02/202423:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202408:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/02/202406:36EDGAR2Form 8-K - Current report
02/02/202406:30GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
31/01/202422:00GLOBECabaletta Bio to Participate in the Guggenheim Healthcare..
20/01/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202421:11EDGAR2Form 8-K - Current report
08/01/202421:00GLOBECabaletta Bio Receives Additional FDA Fast Track..
02/01/202422:00GLOBECabaletta Bio to Present at the 42nd Annual J.P. Morgan..
20/12/202310:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202320:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
29/11/202306:30GLOBECabaletta Bio to Participate in the 6th Annual Evercore ISI..
29/11/202304:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
22/11/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202306:16EDGAR2Form 144 - Report of proposed sale of securities
09/11/202321:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:12EDGAR2Form 8-K - Current report
09/11/202321:00GLOBECabaletta Bio Reports Third Quarter 2023 Financial Results..
06/11/202322:15BWCellares and Cabaletta Bio Partner to Evaluate Automated..
06/11/202321:55DJNCabaletta Bio Gets FDA OK to Study CABA-201 in Generalized..
06/11/202321:03EDGAR2Form 8-K - Current report
06/11/202321:00GLOBECabaletta Bio Receives FDA Clearance of CABA-201 IND..
30/10/202321:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
20/10/202308:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202305:03EDGAR2Form 144 - Report of proposed sale of securities
02/10/202320:38EDGAR2Form 8-K - Current report
02/10/202320:00GLOBECabaletta Bio Receives FDA Clearance of IND Application for..
21/09/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/09/202305:23EDGAR2Form 144 - Report of proposed sale of securities
19/09/202321:00GLOBECabaletta Bio to Participate in Upcoming Investor..
05/09/202321:45EDGAR2Form 8-K - Current report
30/08/202321:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
23/08/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/08/202321:03EDGAR2Form 8-K - Current report
22/08/202321:00GLOBECabaletta Bio and WuXi Advanced Therapies Announce Expansion..
22/08/202305:19EDGAR2Form 144 - Report of proposed sale of securities
10/08/202320:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/08/202320:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:16EDGAR2Form 8-K - Current report
10/08/202320:00GLOBECabaletta Bio Reports Second Quarter 2023 Financial Results..
24/07/202321:06EDGAR2Form 8-K - Current report
24/07/202321:00GLOBECabaletta Bio Appoints Global Commercial Leader Shawn..

최근 히스토리

Delayed Upgrade Clock